Fulgent Genetics (FLGT) Receivables - Other (2016 - 2025)

Fulgent Genetics (FLGT) has 10 years of Receivables - Other data on file, last reported at $1.1 million in Q4 2025.

• Quarterly Receivables - Other fell 35.86% year-over-year to $1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.1 million (down 35.86% YoY) and the FY2025 annual result came in at $1.1 million, down 35.86% from the prior year.
• Receivables - Other slipped to $1.1 million in Q4 2025 per FLGT's latest filing, from $1.4 million in the prior quarter.
• The five-year high for Receivables - Other was $19.8 million in Q4 2022, with the low at $53000.0 in Q2 2023.
• Average Receivables - Other over 5 years is $2.1 million, with a median of $1.3 million recorded in 2024.
• Year-over-year, Receivables - Other slumped 95.61% in 2023 and surged 1513.64% in 2024.
• Fulgent Genetics' Receivables - Other stood at $1.4 million in 2021, then surged by 1313.83% to $19.8 million in 2022, then tumbled by 93.35% to $1.3 million in 2023, then soared by 34.04% to $1.8 million in 2024, then plunged by 35.86% to $1.1 million in 2025.
• Business Quant data shows FLGT's Receivables - Other at $1.1 million in Q4 2025, $1.4 million in Q3 2025, and $2.1 million in Q2 2025.